Leukemia stem cells and constitutive activation of NF-kappaB.
Griffin
J D
JD
Dana-Farber Cancer Institute.
D000818:Animals; D015703:Antigens, CD / Q000097:blood; D018952:Antigens, CD34 / Q000502:physiology; D006412:Hematopoietic Stem Cells / Q000473:pathology / Q000502:physiology*; D006801:Humans; D015470:Leukemia, Myeloid, Acute / Q000473:pathology / Q000503:physiopathology*; D007976:Leupeptins / Q000494:pharmacology; D051379:Mice; D016688:Mice, Inbred NOD; D016513:Mice, SCID; D016328:NF-kappa B / Q000037:antagonists & inhibitors / Q000097:blood*; D011480:Protease Inhibitors / Q000494:pharmacology; D014157:Transcription Factors / Q000037:antagonists & inhibitors / Q000378:metabolism
D015703:Antigens, CD; D018952:Antigens, CD34; D007976:Leupeptins; D016328:NF-kappa B; D011480:Protease Inhibitors; D014157:Transcription Factors; C072553:benzyloxycarbonylleucyl-leucyl-leucine aldehyde